LGND

319.43

0.31% -0.99

시간 외 거래: 318.00 -1.43 -0.45%

리간드 파마 (LGND)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 주식 분할 배당 이력

전일 마감가:

$320.42

열려 있는:

$317.97

하루 거래량:

316.47K

Relative Volume:

0.99

시가총액:

$6.40B

수익:

$274.48M

순이익/손실:

$153.56M

주가수익비율:

43.31

EPS:

7.3755

순현금흐름:

$114.06M

1주 성능:

+1.06%

1개월 성능:

+34.78%

6개월 성능:

+59.75%

1년 성능:

+180.79%

1일 변동 폭

$312.74

$323.30

1주일 범위

$305.31

$323.30

52주 변동 폭

$114.00

$323.30

리간드 파마 Stock (LGND) Company Profile

명칭

Ligand Pharmaceuticals Inc

부문

Healthcare (1094)

산업

Biotechnology (615)

전화

858-550-7500

주소

3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA

직원

트위터

@Ligand_LGND

다음 수익 날짜

2026-08-06

최신 SEC 제출 서류

LGND's Discussions on Twitter

Compare LGND vs VRTX, REGN, ARGX, ALNY, RVMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
LGND Ligand Pharmaceuticals Inc	319.43	6.42B	274.48M	153.56M	114.06M	7.3755
VRTX Vertex Pharmaceuticals Inc	522.25	134.41B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.23	68.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.94	57.01B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.59	41.79B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.46	40.39B	742.00K	-1.37B	-1.07B	-7.0731

리간드 파마 Stock (LGND) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-11	개시	BofA Securities	Buy
2025-12-09	개시	Citigroup	Buy
2025-04-10	개시	Stifel	Buy
2024-10-03	개시	Oppenheimer	Outperform
2024-07-30	개시	RBC Capital Mkts	Outperform
2021-04-14	재개	Stephens	Overweight
2021-02-04	재확인	H.C. Wainwright	Buy
2020-10-06	개시	Barclays	Overweight
2020-03-24	다운그레이드	Argus	Buy → Hold
2020-03-10	개시	Guggenheim	Neutral
2020-02-06	개시	The Benchmark Company	Buy
2019-09-19	업그레이드	Barclays	Equal Weight → Overweight
2019-06-11	개시	Barclays	Equal Weight
2019-05-03	재확인	H.C. Wainwright	Buy
2019-03-06	재확인	H.C. Wainwright	Buy
2018-10-29	업그레이드	ROTH Capital	Neutral → Buy
2018-10-02	재확인	H.C. Wainwright	Buy
2018-09-11	재확인	Argus	Buy
2018-08-17	개시	Goldman	Neutral
2018-08-08	다운그레이드	ROTH Capital	Buy → Neutral
2018-06-21	개시	Argus	Buy
2017-12-27	재확인	H.C. Wainwright	Buy
2017-09-05	재개	H.C. Wainwright	Buy
2016-10-05	재확인	H.C. Wainwright	Buy
2016-08-05	다운그레이드	Deutsche Bank	Hold → Sell
2016-03-11	개시	Sidoti	Buy
2016-03-03	개시	H.C. Wainwright	Buy

모두보기

리간드 파마 주식(LGND)의 최신 뉴스

Jul 06, 2026

Form 4 Ligand Pharmaceuticals Incorporated For: 6 July By Investing.com - Investing.com Canada

Jul 06, 2026

Ligand Pharmaceuticals CLO Andrew Reardon sells $1.56m in shares By Investing.com - Investing.com Canada

Jul 06, 2026

[Form 4] LIGAND PHARMACEUTICALS INC Insider Trading Activity - Stock Titan

Jul 06, 2026

Ligand Pharmaceuticals (LGND) CFO adds 17 shares through stock purchase plan - Stock Titan

Jul 06, 2026

LGND CEO Todd Davis acquires stock through employee plan in Form 4 filing - Stock Titan

Jul 06, 2026

Ligand Pharmaceuticals stock hits all-time high at 321.33 USD - Investing.com

Jul 06, 2026

CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Jul 06, 2026

Jul 03, 2026

Ligand Pharmaceuticals explores licensing-driven growth as investors assess its royalty model - AD HOC NEWS

Jul 03, 2026

Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million -- WSJ - Moomoo

Jul 03, 2026

Jul 02, 2026

Enterprise value to EBITDA forward of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView

Jul 02, 2026

TVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - Stocktwits

Jul 02, 2026

Jul 01, 2026

LGND: 10,000-share Section 144 notice; prior 10b5-1 sales by Reardon (LGND) - Stock Titan

Jul 01, 2026

Enterprise value to revenue forward of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView

Jul 01, 2026

Jun 30, 2026

Ligand Pharma: Expect Bright And Exciting Future For This Growing Royalty Aggregator - Seeking Alpha

Jun 30, 2026

Price to sales forward of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView

Jun 30, 2026

Ligand Pharmaceuticals reaches new 52-week high as insiders trim holdings - AD HOC NEWS

Jun 30, 2026

Zerion Pharma completes royalty financing and equity investment transaction with Ligand to advance the Dispersome® technology - marketscreener.com

Jun 30, 2026

Enterprise value to revenue forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 30, 2026

Jun 29, 2026

Enterprise value to EBITDA forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView

Jun 29, 2026

Price to sales forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 29, 2026

Enterprise value to EBITDA forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 29, 2026

Enterprise value to EBIT forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 29, 2026

Price to book forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 29, 2026

Price to earnings forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 29, 2026

Enterprise value to EBIT forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView

Jun 29, 2026

Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 2000 Value-Defensive Index - marketscreener.com

Jun 29, 2026

Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Enterprise value to EBIT forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView

Jun 29, 2026

Enterprise value to revenue forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView

Jun 29, 2026

Jun 28, 2026

Price to earnings forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView

Jun 28, 2026

Price to earnings forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView

Jun 28, 2026

Price to book forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView

Jun 28, 2026

Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 3000 Value Benchmark - marketscreener.com

Jun 28, 2026

Price to sales forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView

Jun 28, 2026

Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 27, 2026

XOMA Royalty (XOMA) Stock Fair Value Falls After Ligand Agrees Cash Acquisition - Yahoo Finance

Jun 27, 2026

Ligand Pharmaceuticals Incorporated Actuals & Estimates (NASDAQ:LGND) - TradingView

Jun 27, 2026

Jun 26, 2026

Ligand completes $700m convertible notes offering By Investing.com - Investing.com Australia

Jun 26, 2026

LGND Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Ligand Pharmaceuticals Inc (LGND) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 26, 2026

Ligand Pharmaceuticals Incorporated Actuals & Estimates (SWB:LGDN) - TradingView

Jun 26, 2026

Ligand completes $700m convertible notes offering - Investing.com UK

Jun 26, 2026

Jun 25, 2026

LGDN Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Ligand Pharmaceuticals Incorporated Actuals & Estimates (BOATS:LGND) - TradingView

Jun 25, 2026

Ligand Pharmaceuticals Prices Upsized $625 Million Zero-Coupon Convertible Notes Offering to Boost Financial Flexibility and Offset Dilution 1 – Minichart - Minichart

Jun 25, 2026

Ligand Raises $700M Via 0% Convertible Notes, Adds Note Hedges and $524.34 Strike Warrants - TradingView

Jun 25, 2026

Ligand (Nasdaq: LGND) raises $700M in 0% convertible notes with hedges - Stock Titan

Jun 25, 2026

Ligand Pharmaceuticals stock hits all-time high at 289.0 USD By Investing.com - Investing.com Australia

Jun 25, 2026